東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Global pharmaceutical policy

Babar, Zaheer-Ud-Din.

FindBook

Google Book

Amazon

博客來

Global pharmaceutical policy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Global pharmaceutical policy/ edited by Zaheer-Ud-Din Babar.
其他作者:	Babar, Zaheer-Ud-Din.
出版者:	Singapore :Springer Singapore : : 2020.,
面頁冊數:	xviii, 365 p. :ill., digital ;24 cm.
內容註:	1 Medicines Safety in the Gloablized Context -- 2 Managing the Pharmaceutical Supply Chain - To Sustainability and Beyond -- 3 Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy -- 4 Global Access to Cancer Medicines -- 5 Medicines Pricing: Limitations of Existing Policies and New Models -- 6 Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014-2019 -- 7 Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components -- 8 Access to Medicines: Case Studies from Lmics (Russia and Kyrgyzstan) -- 9 Access and Use of Medicines in Ukraine -- 10 Public Participation in Access to Medicines -- 11 Pharmaceutical Policy and Practice: A Review of Synthesis and Studies in China -- 12 Access to Vaccines and Immunization Programme -- 13. Global Antibiotics Use and Resistance -- 14 Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider.
Contained By:	Springer eBooks
標題:	Pharmaceutical policy. -
電子資源:	https://doi.org/10.1007/978-981-15-2724-1
ISBN:	9789811527241

Global pharmaceutical policy
Global pharmaceutical policy[electronic resource] /edited by Zaheer-Ud-Din Babar. - Singapore :Springer Singapore :2020. - xviii, 365 p. :ill., digital ;24 cm.

1 Medicines Safety in the Gloablized Context -- 2 Managing the Pharmaceutical Supply Chain - To Sustainability and Beyond -- 3 Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy -- 4 Global Access to Cancer Medicines -- 5 Medicines Pricing: Limitations of Existing Policies and New Models -- 6 Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014-2019 -- 7 Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components -- 8 Access to Medicines: Case Studies from Lmics (Russia and Kyrgyzstan) -- 9 Access and Use of Medicines in Ukraine -- 10 Public Participation in Access to Medicines -- 11 Pharmaceutical Policy and Practice: A Review of Synthesis and Studies in China -- 12 Access to Vaccines and Immunization Programme -- 13. Global Antibiotics Use and Resistance -- 14 Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider.

Medicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality 'research-based information' in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medicines safety, generic medicines, pharmaceutical supply chain, medicines financing, access and affordability of medicines, rational use of medicines, pharmacy health services research and access to vaccines and biological products. Featuring policy case studies from varied countries such as Mexico, Russia, China, Kyrgyzstan, and Pakistan, this book comprises a valuable and comprehensive resource for students, funders, policymakers, academics, and researchers interested in this field.

ISBN: 9789811527241

Standard No.: 10.1007/978-981-15-2724-1doiSubjects--Topical Terms:

630828
Pharmaceutical policy.

LC Class. No.: RA401.A1 / G56 2020

Dewey Class. No.: 362.1782

Global pharmaceutical policy
LDR:02854nmm a2200325 a 4500 001 2221455
003 DE-He213
005 20201105113513.0
006 m d
007 cr nn 008maaau
008 201216s2020 si s 0 eng d
020 $a 9789811527241 $q (electronic bk.)
020 $a 9789811527234 $q (paper)
024 7 $a 10.1007/978-981-15-2724-1 $2 doi
035 $a 978-981-15-2724-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RA401.A1 $b G56 2020
072 7 $a JHB $2 bicssc
072 7 $a SOC026000 $2 bisacsh
072 7 $a JHB $2 thema
082 0 4 $a 362.1782 $2 23
090 $a RA401.A1 $b G562 2020
245 0 0 $a Global pharmaceutical policy $h [electronic resource] / $c edited by Zaheer-Ud-Din Babar.
260 $a Singapore : $b Springer Singapore : $b Imprint: Palgrave Macmillan, $c 2020.
300 $a xviii, 365 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1 Medicines Safety in the Gloablized Context -- 2 Managing the Pharmaceutical Supply Chain - To Sustainability and Beyond -- 3 Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy -- 4 Global Access to Cancer Medicines -- 5 Medicines Pricing: Limitations of Existing Policies and New Models -- 6 Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014-2019 -- 7 Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components -- 8 Access to Medicines: Case Studies from Lmics (Russia and Kyrgyzstan) -- 9 Access and Use of Medicines in Ukraine -- 10 Public Participation in Access to Medicines -- 11 Pharmaceutical Policy and Practice: A Review of Synthesis and Studies in China -- 12 Access to Vaccines and Immunization Programme -- 13. Global Antibiotics Use and Resistance -- 14 Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider.
520 $a Medicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality 'research-based information' in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medicines safety, generic medicines, pharmaceutical supply chain, medicines financing, access and affordability of medicines, rational use of medicines, pharmacy health services research and access to vaccines and biological products. Featuring policy case studies from varied countries such as Mexico, Russia, China, Kyrgyzstan, and Pakistan, this book comprises a valuable and comprehensive resource for students, funders, policymakers, academics, and researchers interested in this field.
650 0 $a Pharmaceutical policy. $3 630828
650 1 4 $a Sociology, general. $3 1565473
650 2 4 $a Medical Sociology. $3 2182151
650 2 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Health Policy. $3 630834
700 1 $a Babar, Zaheer-Ud-Din. $3 2133282
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-15-2724-1
950 $a Social Sciences (Springer-41176)